CollPlant Biotechnologies (CLGN) Other Operating Expenses (2018 - 2023)

CollPlant Biotechnologies has reported Other Operating Expenses for 4 years, with the latest figure at -$3.4 million in Q1 2023.

• For the quarter ending Q1 2023, Other Operating Expenses rose 7.55% year-over-year to -$3.4 million; the trailing twelve-month figure through Dec 2023 stood at -$3.4 million (up 7.55% YoY), and the FY2020 full-year result was -$8.8 million, down 652.96% from the prior year.
• Other Operating Expenses for Q1 2023 stood at -$3.4 million, up from -$3.7 million in the prior quarter.
• The five-year high for Other Operating Expenses was -$398000.0 in Q3 2019, with the low at -$4.3 million in Q4 2019.
• Historically, Other Operating Expenses has averaged -$2.3 million across 3 years, with a median of -$2.6 million in 2019.
• The largest YoY upside for Other Operating Expenses was 47.0% in 2019 against a maximum downside of 278.48% in 2019.
• CollPlant Biotechnologies' Other Operating Expenses stood at -$4.3 million in 2019, then rose by 14.55% to -$3.7 million in 2022, then advanced by 7.55% to -$3.4 million in 2023.
• The last three Other Operating Expenses figures came in at -$3.4 million (Q1 2023), -$3.7 million (Q1 2022), and -$4.3 million (Q4 2019), per Business Quant data.